Amphotericin B derivatives with improved therapeutic index
Martin D. Burke, Champaign, IL (US); Stephen Davis, Westfield, IN (US); Brice E. Uno, Highland Park, IL (US); Justin Struble, Ballwin, MO (US); Ian Dailey, Maplewood, MN (US); Kaitlyn C. Gray, Freeland, MI (US); David M. Knapp, Arlington, VA (US); Pulin Wang, Austin, TX (US); and Nagarjuna Palyam, Florence, KY (US)
Assigned to The Board of Trustees of the University of Illinois, Urbana, IL (US)
Filed by The Board of Trustees of the University of Illinois, Urbana, IL (US)
Filed on Sep. 2, 2021, as Appl. No. 17/464,916.
Application 17/464,916 is a division of application No. 16/443,728, filed on Jun. 17, 2019, granted, now 11,117,920.
Application 16/443,728 is a division of application No. 15/026,520, granted, now 10,323,057, previously published as PCT/US2014/059334, filed on Oct. 6, 2014.
Claims priority of provisional application 62/045,956, filed on Sep. 4, 2014.
Claims priority of provisional application 61/887,729, filed on Oct. 7, 2013.
Prior Publication US 2022/0056066 A1, Feb. 24, 2022
1. A method of inhibiting growth of a fungus, comprising contacting a fungus with an effective amount of a compound selected from the group consisting of:
